{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:56:07Z","timestamp":1793152567796,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11695-025-07733-8","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:37:39Z","timestamp":1739450259000},"page":"808-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Yuntao","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"7733_CR1","unstructured":"World Obesity Federation. [Internet]. London: World Obesity Federation. World obesity atlas 2024. Available from: https:\/\/data.worldobesity.org\/publications\/?cat=22."},{"issue":"9","key":"7733_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.2014.10706","volume":"312","author":"N Puzziferri","year":"2014","unstructured":"Puzziferri N, Roshek TB 3rd, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934\u201342. https:\/\/doi.org\/10.1001\/jama.2014.10706.","journal-title":"JAMA"},{"issue":"15","key":"7733_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/jama.2018.14433","volume":"320","author":"WC King","year":"2018","unstructured":"King WC, Hinerman AS, Belle SH, et al. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320(15):1560\u20139. https:\/\/doi.org\/10.1001\/jama.2018.14433.","journal-title":"JAMA"},{"issue":"4","key":"7733_CR4","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s11695-020-05160-5","volume":"31","author":"W El Ansari","year":"2021","unstructured":"El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps-a scoping review. Obes Surg. 2021;31(4):1755\u201366. https:\/\/doi.org\/10.1007\/s11695-020-05160-5.","journal-title":"Obes Surg"},{"issue":"26","key":"7733_CR5","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1056\/NEJMoa035622","volume":"351","author":"L Sj\u00f6str\u00f6m","year":"2004","unstructured":"Sj\u00f6str\u00f6m L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683\u201393. https:\/\/doi.org\/10.1056\/NEJMoa035622.","journal-title":"N Engl J Med"},{"issue":"6","key":"7733_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.soard.2018.02.027","volume":"14","author":"B Clapp","year":"2018","unstructured":"Clapp B, Wynn M, Martyn C, et al. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14(6):741\u20137. https:\/\/doi.org\/10.1016\/j.soard.2018.02.027.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"7733_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11695-019-04280-x","volume":"30","author":"S Abdulrazzaq","year":"2020","unstructured":"Abdulrazzaq S, Elhag W, El Ansari W, et al. Is revisional gastric bypass as effective as primary gastric bypass for weight loss and improvement of comorbidities? Obes Surg. 2020;30(4):1219\u201329. https:\/\/doi.org\/10.1007\/s11695-019-04280-x.","journal-title":"Obes Surg"},{"issue":"4","key":"7733_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.soard.2014.09.029","volume":"11","author":"J Homan","year":"2015","unstructured":"Homan J, Betzel B, Aarts EO, et al. Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2015;11(4):771\u20137. https:\/\/doi.org\/10.1016\/j.soard.2014.09.029.","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"7733_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2337\/dc19-1057","volume":"43","author":"A Aminian","year":"2020","unstructured":"Aminian A, Vidal J, Salminen P, et al. Late relapse of diabetes after bariatric surgery: not rare, but not a failure. Diabetes Care. 2020;43(3):534\u201340. https:\/\/doi.org\/10.2337\/dc19-1057.","journal-title":"Diabetes Care"},{"issue":"7","key":"7733_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.soard.2022.04.012","volume":"18","author":"SF Majid","year":"2022","unstructured":"Majid SF, Davis MJ, Ajmal S, et al. Current state of the definition and terminology related to weight recurrence after metabolic surgery: review by the POWER task force of the American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(7):957\u201363. https:\/\/doi.org\/10.1016\/j.soard.2022.04.012.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"7733_CR11","doi-asserted-by":"publisher","first-page":"e000153","DOI":"10.1136\/bmjgast-2017-000153","volume":"4","author":"P Jirapinyo","year":"2017","unstructured":"Jirapinyo P, Abu Dayyeh BK, Thompson CC. Weight regain after Roux-en-Y gastric bypass has a large negative impact on the bariatric quality of life index. BMJ Open Gastroenterol. 2017;4(1):e000153. https:\/\/doi.org\/10.1136\/bmjgast-2017-000153.","journal-title":"BMJ Open Gastroenterol"},{"issue":"5","key":"7733_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s11695-022-05908-1","volume":"32","author":"L Tolvanen","year":"2022","unstructured":"Tolvanen L, Christenson A, Surkan PJ, et al. Patients\u2019 experiences of weight regain after bariatric surgery. Obes Surg. 2022;32(5):1498\u2013507. https:\/\/doi.org\/10.1007\/s11695-022-05908-1.","journal-title":"Obes Surg"},{"key":"7733_CR13","doi-asserted-by":"publisher","unstructured":"Pizato N, Botelho PB, Gon\u00e7alves VSS, et al. Effect of grazing behavior on weight regain post-bariatric surgery: a systematic review. Nutrients. 2017;9(12). https:\/\/doi.org\/10.3390\/nu9121322.","DOI":"10.3390\/nu9121322"},{"issue":"3","key":"7733_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s11695-016-2337-3","volume":"27","author":"LE Bradley","year":"2017","unstructured":"Bradley LE, Forman EM, Kerrigan SG, et al. Project HELP: a remotely delivered behavioral intervention for weight regain after bariatric surgery. Obes Surg. 2017;27(3):586\u201398. https:\/\/doi.org\/10.1007\/s11695-016-2337-3.","journal-title":"Obes Surg"},{"issue":"1","key":"7733_CR15","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41598-020-60044-z","volume":"10","author":"A Marc-Hern\u00e1ndez","year":"2020","unstructured":"Marc-Hern\u00e1ndez A, Ruiz-Tovar J, Aracil A, et al. Effects of a high-intensity exercise program on weight regain and cardio-metabolic profile after 3 years of bariatric surgery: a randomized trial. Sci Rep. 2020;10(1):3123. https:\/\/doi.org\/10.1038\/s41598-020-60044-z.","journal-title":"Sci Rep"},{"issue":"5","key":"7733_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.soard.2014.02.014","volume":"10","author":"SA Brethauer","year":"2014","unstructured":"Brethauer SA, Kothari S, Sudan R, et al. Systematic review on reoperative bariatric surgery: American society for metabolic and bariatric surgery revision task force. Surg Obes Relat Dis. 2014;10(5):952\u201372. https:\/\/doi.org\/10.1016\/j.soard.2014.02.014.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"7733_CR17","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s11695-022-06020-0","volume":"32","author":"RJ Franken","year":"2022","unstructured":"Franken RJ, Sluiter NR, Franken J, et al. Treatment options for weight regain or insufficient weight loss after sleeve gastrectomy: a systematic review and meta-analysis. Obes Surg. 2022;32(6):2035\u201346. https:\/\/doi.org\/10.1007\/s11695-022-06020-0.","journal-title":"Obes Surg"},{"issue":"7","key":"7733_CR18","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s11695-020-04601-5","volume":"30","author":"C Tuero","year":"2020","unstructured":"Tuero C, Valenti V, Rotellar F, et al. Revisiting the ghrelin changes following bariatric and metabolic surgery. Obes Surg. 2020;30(7):2763\u201380. https:\/\/doi.org\/10.1007\/s11695-020-04601-5.","journal-title":"Obes Surg"},{"issue":"6","key":"7733_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/oby.2009.473","volume":"18","author":"M Bose","year":"2010","unstructured":"Bose M, Machineni S, Oliv\u00e1n B, et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring). 2010;18(6):1085\u201391. https:\/\/doi.org\/10.1038\/oby.2009.473.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"7733_CR20","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.dsx.2019.05.002","volume":"13","author":"K Sridharan","year":"2019","unstructured":"Sridharan K, Kalayarasan R, Kamalanathan S, et al. Change in insulin resistance, beta cell function, glucagon-like peptide-1 and calcitonin levels two weeks after bariatric surgery. Diabetes Metab Syndr. 2019;13(3):2142\u20137. https:\/\/doi.org\/10.1016\/j.dsx.2019.05.002.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"7733_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11695-015-1908-z","volume":"26","author":"MA Santo","year":"2016","unstructured":"Santo MA, Riccioppo D, Pajecki D, et al. Weight regain after gastric bypass: influence of gut hormones. Obes Surg. 2016;26(5):919\u201325. https:\/\/doi.org\/10.1007\/s11695-015-1908-z.","journal-title":"Obes Surg"},{"issue":"6","key":"7733_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J van Can","year":"2014","unstructured":"van Can J, Sloth B, Jensen CB, et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 2014;38(6):784\u201393. https:\/\/doi.org\/10.1038\/ijo.2013.162.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"7733_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/dom.14280","volume":"23","author":"M Friedrichsen","year":"2021","unstructured":"Friedrichsen M, Breitschaft A, Tadayon S, et al. The effect of semaglutide 24 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754\u201362. https:\/\/doi.org\/10.1111\/dom.14280.","journal-title":"Diabetes Obes Metab"},{"key":"7733_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-024-01461-2","author":"N \u00c7al\u0131kBa\u015faran","year":"2024","unstructured":"\u00c7al\u0131kBa\u015faran N, Dotan I, Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. Int J Obes (Lond). 2024. https:\/\/doi.org\/10.1038\/s41366-024-01461-2.","journal-title":"Int J Obes (Lond)"},{"key":"7733_CR25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"15","key":"7733_CR26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283(15):2008\u201312. https:\/\/doi.org\/10.1001\/jama.283.15.2008.","journal-title":"Jama"},{"issue":"9","key":"7733_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"7733_CR28","doi-asserted-by":"publisher","first-page":"Ed000142","DOI":"10.1002\/14651858.Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews\u202f: a new edition of the Cochrane Handbook for systematic reviews of interventions. Cochr Database Syst Rev. 2019;10(10):Ed000142. https:\/\/doi.org\/10.1002\/14651858.Ed000142.","journal-title":"Cochr Database Syst Rev"},{"issue":"3","key":"7733_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"3","key":"7733_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1590\/s0100-69912013000300005","volume":"40","author":"D Pajecki","year":"2012","unstructured":"Pajecki D, Halpern A, Cercato C, et al. Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery. Rev Col Bras Cir. 2012;40(3):191\u20135. https:\/\/doi.org\/10.1590\/s0100-69912013000300005.","journal-title":"Rev Col Bras Cir"},{"issue":"11","key":"7733_CR31","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1007\/s11695-018-3393-7","volume":"28","author":"P Rye","year":"2018","unstructured":"Rye P, Modi R, Cawsey S, et al. Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. Obes Surg. 2018;28(11):3553\u20138. https:\/\/doi.org\/10.1007\/s11695-018-3393-7.","journal-title":"Obes Surg"},{"issue":"9","key":"7733_CR32","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1007\/s11695-021-05535-2","volume":"31","author":"MA Rubio","year":"2021","unstructured":"Rubio MA, Ramos-Lev\u00ed AM. Initial experience with alternate-day liraglutide for weight regain following bariatric surgery. Obes Surg. 2021;31(9):4216\u20138. https:\/\/doi.org\/10.1007\/s11695-021-05535-2.","journal-title":"Obes Surg"},{"issue":"2","key":"7733_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11695-023-07053-9","volume":"34","author":"F Vinciguerra","year":"2024","unstructured":"Vinciguerra F, Di Stefano C, Baratta R, et al. Efficacy of high-dose liraglutide 3.0 mg in patients with poor response to bariatric surgery: real-world experience and updated meta-analysis. Obes Surg. 2024;34(2):303\u20139. https:\/\/doi.org\/10.1007\/s11695-023-07053-9.","journal-title":"Obes Surg"},{"key":"7733_CR34","doi-asserted-by":"publisher","first-page":"1183899","DOI":"10.3389\/fnut.2023.1183899","volume":"10","author":"F Vinciguerra","year":"2023","unstructured":"Vinciguerra F, Piazza L, Di Stefano C, et al. High-dose liraglutide improves metabolic syndrome in poor responders to bariatric surgery. Front Nutr. 2023;10:1183899. https:\/\/doi.org\/10.3389\/fnut.2023.1183899.","journal-title":"Front Nutr"},{"issue":"4","key":"7733_CR35","doi-asserted-by":"publisher","first-page":"e12323","DOI":"10.1111\/cob.12323","volume":"9","author":"S Wharton","year":"2019","unstructured":"Wharton S, Kuk JL, Luszczynski M, et al. Liraglutide 30 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery. Clin Obes. 2019;9(4):e12323. https:\/\/doi.org\/10.1111\/cob.12323.","journal-title":"Clin Obes"},{"issue":"5","key":"7733_CR36","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/oby.23736","volume":"31","author":"N Murvelashvili","year":"2023","unstructured":"Murvelashvili N, Xie L, Schellinger JN, et al. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence. Obesity (Silver Spring). 2023;31(5):1280\u20139. https:\/\/doi.org\/10.1002\/oby.23736.","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"7733_CR37","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1007\/s40519-022-01403-9","volume":"27","author":"F Muratori","year":"2022","unstructured":"Muratori F, Vignati F, Di Sacco G, et al. Efficacy of liraglutide 30 mg treatment on weight loss in patients with weight regain after bariatric surgery. Eat Weight Disord. 2022;27(7):2775\u201381. https:\/\/doi.org\/10.1007\/s40519-022-01403-9.","journal-title":"Eat Weight Disord"},{"issue":"10","key":"7733_CR38","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1007\/s11695-022-06211-9","volume":"32","author":"A Lautenbach","year":"2022","unstructured":"Lautenbach A, Wernecke M, Huber TB, et al. The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgery-a retrospective analysis. Obes Surg. 2022;32(10):3280\u20138. https:\/\/doi.org\/10.1007\/s11695-022-06211-9.","journal-title":"Obes Surg"},{"issue":"5","key":"7733_CR39","doi-asserted-by":"publisher","first-page":"e12593","DOI":"10.1111\/cob.12593","volume":"13","author":"A Lautenbach","year":"2023","unstructured":"Lautenbach A, Kantowski T, Wagner J. Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure. Clin Obes. 2023;13(5):e12593. https:\/\/doi.org\/10.1111\/cob.12593.","journal-title":"Clin Obes"},{"issue":"4","key":"7733_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11695-023-06484-8","volume":"33","author":"AB Jensen","year":"2023","unstructured":"Jensen AB, Renstr\u00f6m F, Acz\u00e9l S, et al. Efficacy of the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide for the treatment of weight regain after bariatric surgery: a retrospective observational study. Obes Surg. 2023;33(4):1017\u201325. https:\/\/doi.org\/10.1007\/s11695-023-06484-8.","journal-title":"Obes Surg"},{"issue":"1","key":"7733_CR41","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1002\/osp4.706","volume":"10","author":"M Jamal","year":"2024","unstructured":"Jamal M, Qasem W, Hamshari F, et al. Effectiveness and tolerability of liraglutide for the management of weight regain following sleeve gastrectomy. Obes Sci Pract. 2024;10(1):e706. https:\/\/doi.org\/10.1002\/osp4.706.","journal-title":"Obes Sci Pract"},{"issue":"4","key":"7733_CR42","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11695-024-07137-0","volume":"34","author":"M Jamal","year":"2024","unstructured":"Jamal M, Alhashemi M, Dsouza C, et al. Semaglutide and tirzepatide for the management of weight recurrence after sleeve gastrectomy: a retrospective cohort study. Obes Surg. 2024;34(4):1324\u201332. https:\/\/doi.org\/10.1007\/s11695-024-07137-0.","journal-title":"Obes Surg"},{"issue":"1","key":"7733_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11695-020-04856-y","volume":"31","author":"FF Horber","year":"2021","unstructured":"Horber FF, Steffen R. Reversal of long-term weight regain after Roux-en-Y gastric bypass using liraglutide or surgical revision. A prospective study. Obes Surg. 2021;31(1):93\u2013100. https:\/\/doi.org\/10.1007\/s11695-020-04856-y.","journal-title":"Obes Surg"},{"issue":"5","key":"7733_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/oby.23146","volume":"29","author":"CL Gazda","year":"2021","unstructured":"Gazda CL, Clark JD, Lingvay I, et al. Pharmacotherapies for post-bariatric weight regain: real-world comparative outcomes. Obesity (Silver Spring). 2021;29(5):829\u201336. https:\/\/doi.org\/10.1002\/oby.23146.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"7733_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11695-021-05884-y","volume":"32","author":"W Elhag","year":"2022","unstructured":"Elhag W, El Ansari W. Effectiveness and safety of liraglutide in managing inadequate weight loss and weight regain after primary and revisional bariatric surgery: anthropometric and cardiometabolic outcomes. Obes Surg. 2022;32(4):1005\u201315. https:\/\/doi.org\/10.1007\/s11695-021-05884-y.","journal-title":"Obes Surg"},{"issue":"1","key":"7733_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/oby.23922","volume":"32","author":"JB Bonnet","year":"2023","unstructured":"Bonnet JB, Tournayre S, Anitcheou J, et al. Semaglutide 24 mg\/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery. Obesity (Silver Spring). 2023;32(1):50\u20138. https:\/\/doi.org\/10.1002\/oby.23922.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"7733_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00423-023-02805-8","volume":"408","author":"JRM Colbourne","year":"2023","unstructured":"Colbourne JRM, Fisher OM, Mo S, et al. The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery. Langenbecks Arch Surg. 2023;408(1):115. https:\/\/doi.org\/10.1007\/s00423-023-02805-8.","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"7733_CR48","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamasurg.2023.2930","volume":"158","author":"J Mok","year":"2023","unstructured":"Mok J, Adeleke MO, Brown A, et al. Safety and efficacy of liraglutide, 30 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial. JAMA Surg. 2023;158(10):1003\u201311. https:\/\/doi.org\/10.1001\/jamasurg.2023.2930.","journal-title":"JAMA Surg"},{"issue":"2","key":"7733_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/dom.14232","volume":"23","author":"L Ji","year":"2021","unstructured":"Ji L, Dong X, Li Y, et al. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: a 30-week, double-blind, phase 3a, randomized trial. Diabetes Obes Metab. 2021;23(2):404\u201314. https:\/\/doi.org\/10.1111\/dom.14232.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"7733_CR50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"issue":"3","key":"7733_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2206038.","journal-title":"N Engl J Med"},{"issue":"43","key":"7733_CR52","doi-asserted-by":"publisher","first-page":"e35739","DOI":"10.1097\/md.0000000000035739","volume":"102","author":"X Yuan","year":"2023","unstructured":"Yuan X, Gao Z, Hao Z, et al. Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: a head-to-head meta-analysis. Medicine (Baltimore). 2023;102(43):e35739. https:\/\/doi.org\/10.1097\/md.0000000000035739.","journal-title":"Medicine (Baltimore)"},{"key":"7733_CR53","doi-asserted-by":"publisher","first-page":"173823","DOI":"10.1016\/j.ejphar.2020.173823","volume":"893","author":"P Nowrouzi-Sohrabi","year":"2021","unstructured":"Nowrouzi-Sohrabi P, Rezaei S, Jalali M, et al. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Pharmacol. 2021;893:173823. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173823.","journal-title":"Eur J Pharmacol"},{"issue":"10278","key":"7733_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/s0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, et al. Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(21)00213-0.","journal-title":"Lancet"},{"issue":"10148","key":"7733_CR55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0140-6736(18)31773-2","volume":"392","author":"PM O\u2019Neil","year":"2018","unstructured":"O\u2019Neil PM, Birkenfeld AL, McGowan B, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018;392(10148):637\u201349. https:\/\/doi.org\/10.1016\/s0140-6736(18)31773-2.","journal-title":"Lancet"},{"issue":"9","key":"7733_CR56","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1007\/s11695-020-04536-x","volume":"30","author":"N Poublon","year":"2020","unstructured":"Poublon N, Chidi I, Bethlehem M, et al. One anastomosis gastric bypass vs Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgery. Obes Surg. 2020;30(9):3287\u201394. https:\/\/doi.org\/10.1007\/s11695-020-04536-x.","journal-title":"Obes Surg"},{"issue":"5\u20136","key":"7733_CR57","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","volume":"62","author":"SE Kanoski","year":"2012","unstructured":"Kanoski SE, Rupprecht LE, Fortin SM, et al. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology. 2012;62(5\u20136):1916\u201327. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.022.","journal-title":"Neuropharmacology"},{"issue":"3","key":"7733_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","volume":"16","author":"HJ Grill","year":"2012","unstructured":"Grill HJ, Hayes MR. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab. 2012;16(3):296\u2013309. https:\/\/doi.org\/10.1016\/j.cmet.2012.06.015.","journal-title":"Cell Metab"},{"issue":"4","key":"7733_CR59","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.suc.2016.03.004","volume":"96","author":"NJ Switzer","year":"2016","unstructured":"Switzer NJ, Karmali S, Gill RS, et al. Revisional bariatric surgery. Surg Clin North Am. 2016;96(4):827\u201342. https:\/\/doi.org\/10.1016\/j.suc.2016.03.004.","journal-title":"Surg Clin North Am"},{"issue":"3","key":"7733_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1503\/cjs.006116","volume":"60","author":"C Fulton","year":"2017","unstructured":"Fulton C, Sheppard C, Birch D, Karmali S, de Gara C. A comparison of revisional and primary bariatric surgery. Can J Surg. 2017;60(3):205\u201311. https:\/\/doi.org\/10.1503\/cjs.006116.","journal-title":"Can J Surg"},{"issue":"9","key":"7733_CR61","doi-asserted-by":"publisher","first-page":"e3778","DOI":"10.1210\/clinem\/dgab301","volume":"106","author":"S Kubota","year":"2021","unstructured":"Kubota S, Yabe D. Elevation of fasting GLP-1 levels in child and adolescent obesity: friend or foe? J Clin Endocrinol Metab. 2021;106(9):e3778\u201380. https:\/\/doi.org\/10.1210\/clinem\/dgab301.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"7733_CR62","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1007\/s11695-021-05568-7","volume":"31","author":"C Lampropoulos","year":"2021","unstructured":"Lampropoulos C, Alexandrides T, Tsochatzis S, et al. Are the changes in gastrointestinal hormone secretion necessary for the success of bariatric surgery? A critical review of the literature. Obes Surg. 2021;31(10):4575\u201384. https:\/\/doi.org\/10.1007\/s11695-021-05568-7.","journal-title":"Obes Surg"},{"issue":"2","key":"7733_CR63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5114\/pm.2022.116492","volume":"21","author":"C Lampropoulos","year":"2022","unstructured":"Lampropoulos C, Mulita F, Alexandrides T, et al. Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study. Prz Menopauzalny. 2022;21(2):97\u2013105. https:\/\/doi.org\/10.5114\/pm.2022.116492.","journal-title":"Prz Menopauzalny"},{"key":"7733_CR64","doi-asserted-by":"publisher","unstructured":"Bednarz K, Kowalczyk K, Cwynar M, et al. The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci. 2022;23(8). https:\/\/doi.org\/10.3390\/ijms23084334.","DOI":"10.3390\/ijms23084334"},{"issue":"Suppl 1","key":"7733_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcpt.13230","volume":"45","author":"S Cornell","year":"2020","unstructured":"Cornell S. A review of GLP-1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once-weekly agents. J Clin Pharm Ther. 2020;45(Suppl 1):17\u201327. https:\/\/doi.org\/10.1111\/jcpt.13230.","journal-title":"J Clin Pharm Ther"},{"key":"7733_CR66","doi-asserted-by":"publisher","first-page":"1043595","DOI":"10.3389\/fendo.2022.1043595","volume":"13","author":"E Lucas","year":"2022","unstructured":"Lucas E, Simmons O, Tchang B, et al. Pharmacologic management of weight regain following bariatric surgery. Front Endocrinol (Lausanne). 2022;13:1043595. https:\/\/doi.org\/10.3389\/fendo.2022.1043595.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"7733_CR67","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s2213-8587(19)30157-3","volume":"7","author":"AD Miras","year":"2019","unstructured":"Miras AD, P\u00e9rez-Pevida B, Aldhwayan M, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549\u201359. https:\/\/doi.org\/10.1016\/s2213-8587(19)30157-3.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-07733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-07733-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-07733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:36:48Z","timestamp":1741858608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-07733-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7733"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-07733-8","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent does not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}